Methods of increasing natural killer cell activity for therapy

Details for Australian Patent Application No. 2006236534 (hide)

Owner Synta Pharmaceuticals Corp.

Inventors Du, Zhenjian; Barsoum, James

Agent Davies Collison Cave

Pub. Number AU-A-2006236534

PCT Pub. Number WO2006/113572

Priority 60/671,910 15.04.05 US

Filing date 13 April 2006

Wipo publication date 26 October 2006

International Classifications

A61K 31/16 (2006.01) - Amides, e.g. hydroxamic acids

A61K 31/165 (2006.01) - having aromatic rings, e.g. colchicine, atenolol, progabide

A61P 37/04 (2006.01) Drugs for immunological or allergic disorders

Event Publications

25 October 2007 PCT application entered the National Phase

  PCT publication WO2006/113572 Priority application(s): WO2006/113572

6 January 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006236536-Adjustable height high heel shoe

2006236527-Ballast water electromagnetic heating technique